July 22, 2010 – Accumetrics Inc., Daiichi Sankyo Inc., and Eli Lilly and Co. recently announced that they have ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
July 13, 2010 – AstraZeneca recently announced that the U.S. District Court has found that the substance patent ...
July 1, 2010 – Two medical companies say they will work with physicians to further investigate ways to manage ...
July 1, 2010 – The U.S. Food and Drug Administration (FDA) recently added a warning to the information on ...
June 24, 2010 – The first cohort of patients was fully enrolled this week in a clinical study of a new drug meant ...
June 14, 2010 - High levels of high-density lipoprotein (HDL) — known as good cholesterol — can not only make a ...
June 8, 2010 – New study findings prove continuing warfarin therapy during pacemaker or defibrillator implantation ...
June 2, 2010 – A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was ...
May 4, 2010 – A deal has been struck to produce a generic version of Merck & Company’s Zetia (ezetimibe). In the ...
April 27, 2010 – A popular statin gained a new indication today in the European Union for prevention of major ...
April 22, 2010 — An improved formulation of epoprostenol for the treatment of primary pulmonary arterial ...
April 19, 2010 – The U.S. Food and Drug Administration (FDA) recently cleared a generic version of metoprolol ...
April 9, 2010 – A preclinical study shows the action of a toll-like receptor (TLR) antagonist helps reduce ...
March 30, 2010 – The FDA granted tentative approval for Teva Pharmaceutical’s abbreviated new drug application ...
March 18, 2010 – The U.S. Food and Drug Administration (FDA) today added a boxed warning to the anti-blood ...